Oral semaglutide demonstrated superior cardiometabolic outcomes relative to placebo and active comparators, including empaglifozin, in T2D.

That is why the current wave of fake Ozempic-style drugs now circulating in the U.S by unlicensed and often foreign companies ...

Two years on from The Royal Gazette’s first report on a new wave of diabetes drugs with broader health benefits, the island’s ...

Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for cardiometabolic diseases and GI oncological indications announced today that it ...

Many Americans are taking GLP1 medications, which include weight loss and diabetes medications Ozempic and Wegovy.

Ozempic, a popular drug for type 2 diabetes, has gained traction for its weight loss benefits, but it comes with potential ...

Eli Lilly and Company LLY will report its first-quarter earnings on May 1, before market open. The Zacks Consensus Estimate ...